Clinical Trial Update: A Study of LAD191 in Adults With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating LAD191 for hidradenitis suppurativa. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• LAD191

Snippet

Sponsor: Almirall, S.A. | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: NOT_YET_RECRUITING